HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Dynavax Technologies, maintaining a price target of $29.
October 15, 2024 | 9:53 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Dynavax Technologies, maintaining a price target of $29.
The reiteration of a Buy rating and maintenance of a $29 price target by HC Wainwright & Co. is a positive signal for investors, suggesting confidence in Dynavax Technologies' future performance. This could lead to increased investor interest and potentially a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100